Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection
- 1 May 2011
- journal article
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 177 (1) , 29-34
Abstract
No abstract availableKeywords
Funding Information
- United States National Institutes of Health (AI028398, U01AI075594, AI053680)
- Drexel University College of Medicine
- Welch Foundation
This publication has 16 references indexed in Scilit:
- Identification of a Metabolically Stable Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Antimalarial Activity in MiceJournal of Medicinal Chemistry, 2009
- Comparative genomics of the neglected human malaria parasite Plasmodium vivaxNature, 2008
- The genome of the simian and human malaria parasite Plasmodium knowlesiNature, 2008
- Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitors with Potent and Selective Activity against the Malaria Parasite Plasmodium falciparumJournal of Medicinal Chemistry, 2008
- Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparumNature, 2007
- A blasticidin S-resistant Plasmodium falciparum mutant with a defective plasmodial surface anion channelProceedings of the National Academy of Sciences, 2007
- Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoeliiNature, 2002
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002
- Circumsporozoite protein is required for development of malaria sporozoites in mosquitoesNature, 1997
- Conversion of dihydroorotate to orotate in parasitic protozoaBiochimica et Biophysica Acta (BBA) - General Subjects, 1979